These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3526070)

  • 21. Ultrastructural study of the testicular interstitial cells and the prostate involution in rats bearing a transplantable prolactin and growth hormone-producing tumor.
    Perotti ME; Fang VS
    J Ultrastruct Res; 1975 Aug; 52(2):202-16. PubMed ID: 168397
    [No Abstract]   [Full Text] [Related]  

  • 22. Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
    Mashiter K; Adams E; Beard M; Holley A
    Lancet; 1977 Jul; 2(8030):197-8. PubMed ID: 69814
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin and glucagon in rats with islet cell tumors induced by small doses of streptozotocin.
    Yoshino G; Kazumi T; Morita S; Baba S
    Can J Physiol Pharmacol; 1981 Aug; 59(8):818-23. PubMed ID: 6271376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effect of glucose administration on the binding of prolactin by rat liver.
    Goodman AD; Hoekstra S; Monahan JW; Danis EH
    Metabolism; 1990 Jun; 39(6):568-76. PubMed ID: 2191185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J; Chevallier P; Remy C; Rajas F; Cohen R; Calle A; Hooghe-Peters EL; Rousset B
    Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dopaminergic blockade on the secretion of growth hormone and prolactin in man.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Metabolism; 1978 Aug; 27(8):921-6. PubMed ID: 672613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat.
    Trouillas J; Chevallier P; Claustrat B; Hooghe-Peters E; Dubray C; Rousset B; Girod C
    Endocrinology; 1994 Jan; 134(1):401-10. PubMed ID: 7903933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the response to insulin in the normal subhuman pregnant primate.
    Chez RA; Mintz DH; Horger EO; Hutchinson DL
    J Clin Invest; 1970 Aug; 49(8):1517-27. PubMed ID: 4988208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone.
    del Pozo E; Schlüter K; Nüesch E; Rosenthaler J; Kerp L
    Eur J Clin Pharmacol; 1986; 29(5):615-8. PubMed ID: 3956565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bromocriptine alters hormone rhythms and lipid metabolism in swine.
    Cincotta AH; Meier AH; Southern LL
    Ann Nutr Metab; 1989; 33(6):305-14. PubMed ID: 2694921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
    Krysiak R; Okopien B
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of arginine aspartate and its components on growth hormone, insulin and glucagon secretion in the rat.
    Franchimont P; Campistron G; Creuzet MH; Gros J; Luyckx A
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):161-8. PubMed ID: 6372719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon, insulin, growth hormone, and glucose concentrations in blood plasma of lactating dairy cows.
    Herbein JH; Aiello RJ; Eckler LI; Pearson RE; Akers RM
    J Dairy Sci; 1985 Feb; 68(2):320-5. PubMed ID: 3886730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin: a diabetogenic hormone.
    Landgraf R; Landraf-Leurs MM; Weissmann A; Hörl R; von Werder K; Scriba PC
    Diabetologia; 1977 Apr; 13(2):99-104. PubMed ID: 852641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine redirects metabolism and prevents seasonal onset of obese hyperinsulinemic state in Syrian hamsters.
    Cincotta AH; MacEachern TA; Meier AH
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E285-93. PubMed ID: 8447396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin secretion in mammosomatotropic tumor-bearing and pregnant rats. A role for lactogens.
    Sorenson RL; Parsons JA
    Diabetes; 1985 Apr; 34(4):337-41. PubMed ID: 2857670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
    Muechler EK; Huang KE; McDonald JV; Tang L
    Am J Obstet Gynecol; 1987 Aug; 157(2):453-5. PubMed ID: 3113252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
    Cronin MJ; Thorner MO
    J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine and glucose tolerance in acromegalics.
    Dolecek R; Kubis M; Sajnar J; Závada M
    Pharmatherapeutica; 1982; 3(2):100-6. PubMed ID: 7048336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.